{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:40Z","timestamp":1790015500798,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012533","name":"Minia University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012533","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A rapid, sensitive, and eco-friendly spectrophotometric method was developed for the quantitative determination of moxifloxacin (MOX) based on ion-pair formation with erythrosine B (EB). The resulting pink-colored ion pair complex exhibited a maximum absorbance at 554\u00a0nm. Systematic optimization of reaction parameters, including buffer pH, dye concentration, and diluent selection, ensured maximum sensitivity and reproducibility. The method demonstrated excellent linearity within the concentration range of 0.2\u20131.2\u00a0\u00b5g mL\n                    <jats:sup>\u2212\u20091<\/jats:sup>\n                    (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.9990), with low detection and quantification limits (LOD\u2009=\u20090.05\u00a0\u00b5g mL\n                    <jats:sup>\u2212\u20091<\/jats:sup>\n                    , LOQ\u2009=\u20090.15\u00a0\u00b5g mL\n                    <jats:sup>\u2212\u20091<\/jats:sup>\n                    ). The calculated molar absorptivity (3.41\u2009\u00d7\u200910\u2075 L\u00b7mol\u207b\u00b9\u00b7cm\u207b\u00b9) and Sandell\u2019s sensitivity (1.18\u2009\u00d7\u200910\u207b\u00b3 \u00b5g\u00b7cm\u207b\u00b2 per 0.001 absorbance unit) confirmed the high analytical sensitivity of the proposed method. Validation in accordance with ICH guidelines demonstrated excellent accuracy (mean recoveries of 99.43\u201399.77%), precision (RSD\u2009&lt;\u20091.7%), and robustness against minor variations in experimental conditions. Application of the proposed method to commercial eye-drop formulation produced recoveries ranging from 99.1% to 100.46%. Statistical comparison with reference method revealed no significant differences (\n                    <jats:italic>t-<\/jats:italic>\n                    value\u2009=\u20091.008,\n                    <jats:italic>F-<\/jats:italic>\n                    value\u2009=\u20091.124). These findings establish the proposed assay as equivalent in accuracy and precision to established techniques, while offering practical simplicity, cost-effectiveness, and environmental compatibility. By eliminating organic solvents and minimizing reagent consumption, the method aligns with green chemistry principles and provides a practical, sustainable tool for routine pharmaceutical quality control.\n                  <\/jats:p>","DOI":"10.1186\/s13065-026-01879-x","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:05:28Z","timestamp":1784124328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eco-friendly spectrophotometric determination of moxifloxacin in pharmaceutical dosage form via ion-pair complexation with erythrosine B"],"prefix":"10.1186","volume":"20","author":[{"given":"Tamer Z.","family":"Attia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa Mohamed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena A. M.","family":"Nour El-Deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"1","key":"1879_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0924-8579(00)00192-8","volume":"16","author":"P Appelbaum","year":"2000","unstructured":"Appelbaum P, Hunter P. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents. 2000;16(1):5\u201315.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"1879_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jcph.1358","volume":"59","author":"H Stass","year":"2019","unstructured":"Stass H, et al. Pharmacokinetics, safety, and tolerability of single-dose intravenous moxifloxacin in pediatric patients: dose optimization in a phase 1 study. J Clin Pharmacol. 2019;59(5):654\u201367.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"1879_CR3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1185\/030079907X188099","volume":"23","author":"PB Iannini","year":"2007","unstructured":"Iannini PB. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Curr Med Res Opin. 2007;23(6):1403\u201313.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"1879_CR4","first-page":"625","volume":"73","author":"W Wichitnithad","year":"2018","unstructured":"Wichitnithad W, et al. A simple and sensitive HPLC-fluorescence method for the determination of moxifloxacin in human plasma and its application in a pharmacokinetic study. Die Pharmazie-An Int J Pharm Sci. 2018;73(11):625\u20139.","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"issue":"1","key":"1879_CR5","first-page":"462918","volume":"2013","author":"N Wang","year":"2013","unstructured":"Wang N, et al. Improved HPLC method for the determination of moxifloxacin in application to a pharmacokinetics study in patients with infectious diseases. Int Sch Res Notices. 2013;2013(1):462918.","journal-title":"Int Sch Res Notices"},{"key":"1879_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1590\/S1517-83822012000400008","volume":"43","author":"AA Abdelaziz","year":"2012","unstructured":"Abdelaziz AA, Elbanna TE, Gamaleldeen NM. Validated microbiological and HPLC methods for the determination of moxifloxacin in pharmaceutical preparations and human plasma. Brazilian J Microbiol. 2012;43:1291\u2013301.","journal-title":"Brazilian J Microbiol"},{"issue":"1","key":"1879_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/10826076.2017.1280680","volume":"40","author":"A Czyrski","year":"2017","unstructured":"Czyrski A, Sok\u00f3\u0142 A, Sza\u0142ek E. HPLC method for determination of moxifloxacin in plasma and its application in pharmacokinetic analysis. J Liq Chromatogr Relat Technol. 2017;40(1):8\u201312.","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"2","key":"1879_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jpba.2009.03.029","volume":"50","author":"P Djurdjevic","year":"2009","unstructured":"Djurdjevic P, et al. Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC. J Pharm Biomed Anal. 2009;50(2):117\u201326.","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"1879_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3390\/ijerph16071196","volume":"16","author":"M Attimarad","year":"2019","unstructured":"Attimarad M, Shahzad Chohan M, Ahmed A, Balgoname. Simultaneous determination of moxifloxacin and flavoxate by RP-HPLC and ecofriendly derivative spectrophotometry methods in formulations. Int J Environ Res Public Health. 2019;16(7):1196.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"1879_CR10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/00032710902890363","volume":"42","author":"Y Fan","year":"2009","unstructured":"Fan Y, Tian Z, Qin W. Quick and sensitive determination of fluoroquinolones by capillary electrophoresis\u2013potential gradient detection. Anal Lett. 2009;42(8):1057\u201369.","journal-title":"Anal Lett"},{"issue":"1\u20132","key":"1879_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0378-4347(98)00302-8","volume":"716","author":"J-G M\u00f6ller","year":"1998","unstructured":"M\u00f6ller J-G, et al. Capillary electrophoresis with laser-induced fluorescence: a routine method to determine moxifloxacin in human body fluids in very small sample volumes. J Chromatogr B Biomed Sci Appl. 1998;716(1\u20132):325\u201334.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"1879_CR12","doi-asserted-by":"publisher","first-page":"125201","DOI":"10.1016\/j.saa.2024.125201","volume":"326","author":"TZ Attia","year":"2025","unstructured":"Attia TZ, et al. Enhancement of sensitivity for moxifloxacin spectrofluorimetric analysis through photoinduced electron transfer inhibition. Green assessment with application to pharmaceutical eye drops. Spectrochim Acta Part A Mol Biomol Spectrosc. 2025;326:125201.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"issue":"1","key":"1879_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21608\/ejchem.2012.1128","volume":"55","author":"BA Balboul","year":"2012","unstructured":"Balboul BA, et al. Synthesis, characterization, spectrofluorometric and antibacterial activity studies of moxifloxacin-zirconium complex. Egypt J Chem. 2012;55(1):15\u201331.","journal-title":"Egypt J Chem"},{"issue":"4","key":"1879_CR14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.52711\/0974-360X.2021.00332","volume":"14","author":"N Ibrahim","year":"2021","unstructured":"Ibrahim N, et al. Development, optimization, and validation of a green spectrofluorimetric method for the determination of moxifloxacin using an experimental design approach. Res J Pharm Technol. 2021;14(4):1880\u20136.","journal-title":"Res J Pharm Technol"},{"key":"1879_CR15","unstructured":"Jasmin Shah JS et al. Micellar-enhanced spectrofluorometric quantification of moxifloxacin in pharmaceutical formulations, human urine and plasma samples. 2011."},{"key":"1879_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.saa.2011.10.051","volume":"86","author":"M Kamruzzaman","year":"2012","unstructured":"Kamruzzaman M, et al. Spectrofluorimetric study of the interaction between europium (III) and moxifloxacin in micellar solution and its analytical application. Spectrochim Acta Part A Mol Biomol Spectrosc. 2012;86:375\u201380.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"issue":"12","key":"1879_CR17","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1039\/b005991i","volume":"125","author":"JA Oca\u00f1a","year":"2000","unstructured":"Oca\u00f1a JA, Barrag\u00e1n FJ, Callej\u00f3n M. Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum. Analyst. 2000;125(12):2322\u20135.","journal-title":"Analyst"},{"issue":"1","key":"1879_CR18","doi-asserted-by":"publisher","first-page":"015010","DOI":"10.1088\/2050-6120\/ad1249","volume":"12","author":"WM Othman","year":"2023","unstructured":"Othman WM, et al. Development and validation of synchronous spectrofluorimetric method for the simultaneous determination of duvelisib and moxifloxacin: greenness metric assessment and application to a pharmacokinetic study in rats. Methods Appl Fluoresc. 2023;12(1):015010.","journal-title":"Methods Appl Fluoresc"},{"issue":"4","key":"1879_CR19","first-page":"252","volume":"5","author":"S Patel","year":"2013","unstructured":"Patel S, Raval M, Shah U. Development and validation of spectrofluorometric method for the estimation of moxifloxacin in pharmaceutical dosage form. Int J Pharm Pharm Sci. 2013;5(4):252\u20134.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1879_CR20","doi-asserted-by":"crossref","unstructured":"Shah J et al. Sensitive spectrofluorimetric method for determination of fluoroquinolones through charge-transfer complex formation. American Journal of Analytical Chemistry, 2013;2013.","DOI":"10.4236\/ajac.2013.410066"},{"issue":"1","key":"1879_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.saa.2008.08.017","volume":"72","author":"ST Ulu","year":"2009","unstructured":"Ulu ST. Spectrofluorimetric determination of fluoroquinolones in pharmaceutical preparations. Spectrochim Acta Part A Mol Biomol Spectrosc. 2009;72(1):138\u201343.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"1879_CR22","unstructured":"Elbashir AA et al. New spectrophotometric methods for the determination of moxifloxacin in pharmaceutical formulations. Acta chimica Slovenica, 2013;60(1)."},{"key":"1879_CR23","unstructured":"Sahu S, Azam M, Sahu D. Spectrophotometric estimation of moxifloxacin in bulk and its pharmaceutical formulations. 2011;2(4)."},{"issue":"11","key":"1879_CR24","first-page":"21","volume":"7","author":"N Pradhan","year":"2015","unstructured":"Pradhan N, et al. Simultaneous spectrophotometric estimation of moxifloxacin hydrochloride and doxorubicin hydrochloride. Int J Pharm Pharm Sci. 2015;7(11):21\u20136.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1879_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.saa.2014.12.111","volume":"140","author":"S Ashour","year":"2015","unstructured":"Ashour S, Bayram R. Development and validation of sensitive kinetic spectrophotometric method for the determination of moxifloxacin antibiotic in pure and commercial tablets. Spectrochim Acta Part A Mol Biomol Spectrosc. 2015;140:216\u201322.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"1879_CR26","doi-asserted-by":"publisher","first-page":"ACI","DOI":"10.4137\/ACI.S8090","volume":"6","author":"LM Abdellaziz","year":"2011","unstructured":"Abdellaziz LM, Hosny MM. Development and validation of spectrophotometric, atomic absorption and kinetic methods for determination of moxifloxacin hydrochloride. Anal Chem Insights. 2011;6:ACI.","journal-title":"Anal Chem Insights"},{"issue":"1","key":"1879_CR27","doi-asserted-by":"publisher","first-page":"16718","DOI":"10.1038\/s41598-025-00733-9","volume":"15","author":"AM Hamdy","year":"2025","unstructured":"Hamdy AM, El Henawee MM, Hashem H, Meselhy EM, Ibrahim H. Advanced eco-friendly spectrophotometric analysis for Nebivolol, Valsartan, and related impurity with comprehensive environmental impact assessment. Sci Rep. 2025;15(1):16718.","journal-title":"Sci Rep"},{"issue":"1","key":"1879_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13065-025-01528-9","volume":"19","author":"A Alshehri","year":"2025","unstructured":"Alshehri A, Alqahtani A, Alsayari A, Almrasy AA. An eco-friendly chemometrics assisted UV spectrophotometric method for simultaneous determination of sofosbuvir, simeprevir and ledipasvir in pharmaceuticals. BMC Chem. 2025;19(1):156.","journal-title":"BMC Chem"},{"issue":"4","key":"1879_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/bio.4467","volume":"38","author":"HA Ahmad","year":"2023","unstructured":"Ahmad HA, Hassan RO. Newly synthesized Fe-doped CDs for colorimetric and fluorometric nanozyme-based levodopa sensing. Luminescence: J Biol Chem Luminescence. 2023;38(4):437\u201349.","journal-title":"Luminescence: J Biol Chem Luminescence"},{"key":"1879_CR30","doi-asserted-by":"crossref","unstructured":"Ali DS, Othman HO, Hassan RO. Green microextraction, paper-based technique, and smartphone sensing for sustainable determination of nicotinamide in pharmaceuticals and blood samples. Chemistry & Biodiversity; 2025.","DOI":"10.1002\/cbdv.202403248"},{"key":"1879_CR31","unstructured":"ICH Guideline Q2(R1): Validation of Analytical Procedures \u2013 Text and Methodology. International Conference on Harmonization, 2005."}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01879-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:12:29Z","timestamp":1784128349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01879-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1879"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01879-x","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"157"}}